Travaux scientifiques

Doç. Dr. Senem Maral

152 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. PB2013 LACTATE DEHYDROGENASE LEVEL IS ASSOCIATED WITH A WORSE OUTCOME IN TURKISH PATIENTS WITH HAIRY CELL LEUKEMIA

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000566544.13472.66 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  2. A first time report on the coocurrence of sarcoidosis and ALK(−) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219837331 PMID 30909793 Source : OpenAlex

  3. A rare cause of hemophagocytic lymphohistiocytosis Q fever: a case report

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30374-1 Source : OpenAlex

  4. Clinical features and possible prognostic factors in patients with marginal zone lymphoma: retrospective analysis from two centers

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30277-2 Source : OpenAlex

  5. A rare association, myelofibrosis secondary to essential thrombocytosis and monoclonal gammopathy of undetermined significance

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30313-3 Source : OpenAlex

  6. Assessment of Clinical Course, Prognostic Features, and Treatment Response of Patients with Chronic Lymphocytic Leukemia: A Single Center Experience

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.41033 Source : OpenAlex

  7. Dimethyl Sulfoxide-Induced Tonic-Clonic Seizure and Cardiac Arrest During Infusion of Autologous Peripheral Blood Stem Cells

    Cell and Tissue Banking, 2018

    DOI 10.1007/s10561-018-9718-x PMID 30099684 24 citations (Europe PMC) Source : OpenAlex

  8. Infections in patients with lymphoma: An analysis of incidence, relationship and risk factors

    The Journal of Infection in Developing Countries, 2018

    DOI 10.3855/jidc.10399 PMID 31999632 6 citations (Europe PMC) Source : OpenAlex

  9. Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience

    Journal of Oncology Pharmacy Practice, 2018

    DOI 10.1177/1078155218795323 PMID 30134766 3 citations (Europe PMC) Source : OpenAlex

  10. Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate

    Journal of Cancer Research and Therapeutics, 2018

    DOI 10.4103/0973-1482.192762 PMID 30488870 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  11. Current Treatment Approaches to Multiple Myeloma with New Agents

    Journal of Clinical and Experimental Investigations, 2018

    DOI 10.5799/jcei.433823 Source : OpenAlex

  12. The rare coexistence of high titer inhibitor development and gastrointestinal stromal tumor in a patient with severe hemophilia: A case report

    Transfusion and Apheresis Science, 2018

    DOI 10.1016/j.transci.2018.04.023 PMID 29724628 1 citation (Europe PMC) Source : OpenAlex

  13. Epidemiological and survival data of adult lymphoma patients: single centre experience

    Ortadoğu Tıp Dergisi, 2018

    DOI 10.21601/ortadogutipdergisi.395616 Source : OpenAlex

  14. Acquired hemophilia with thrombosis in a cancer patient

    Blood Coagulation & Fibrinolysis, 2017

    DOI 10.1097/mbc.0000000000000670 PMID 29095762 2 citations (Europe PMC) Source : OpenAlex

  15. Rare aggressive natural killer cell leukemia presented with leukopenia and disseminated intravascular coagulation—a diagnostic challenge

    Journal of Hematopathology, 2017

    DOI 10.1007/s12308-017-0313-z Source : OpenAlex

  16. Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases

    Medicine, 2015

    DOI 10.1097/md.0000000000000732 PMID 25906101 12 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  17. An Independent Risk Factor For Quality of Life In Cancer Patients: Urinary Incontinence

    Acta Medica Anatolia, 2015

    DOI 10.15824/actamedica.30987 Source : OpenAlex

  18. J Oncol Pharm Pract. 2019 Jul 30:1078155219863469. doi: 10.1177/1078155219863469

    Source : page de profil sur medipol.com.tr

  19. 7. A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase I Clinical Study to Demonstrate Safety of Ankaferd Blood Stopper Topical Usage In Healthy Volunteers. Balcik OS, Koroglu M, Cipil H, Kaftan O, Maral S, Gurel A, Goker H, Haznedaroglu IC, Kosar A. UHOD 2012:22(4 );267-274 doi: 10.4999/uhod.10124

    Source : page de profil sur medipol.com.tr

  20. 14. CD25 Expression is Associated with Autoimmunity in Patients with CLL .Ozturk Hb, Yıldız A, Albayrak M, Pala C, Maral S, Falay M . UHOD. 2019:29;123-129 doi: 10.4999/uhod.193789

    Source : page de profil sur medipol.com.tr

  21. 21. A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase I Clinical Study To Demonstrate Safety of Ankaferd Blood Stopper Topical Usage In Healthy Volunteers: 336 Balcik OS, Koroglu M, Cipil H, Kaftan O, Maral S, Gurel A, Goker H, Haznedaroglu IC, Kosar A. Int J Lab Hematol 2010;32:126-127.

    Source : page de profil sur medipol.com.tr

  22. 27. Modified R-IDARAM treatment in central nervous system lymphomas: A single centre experience. Maral S, Albayrak M, Pala C, Ozturk HBA, Yıldız A, Şahin O, Okutan H. Avicenna J Med. 2020: 10( 4): 227-231 DOI: 10.4103/ajm.ajm_59_19

    Source : page de profil sur medipol.com.tr

  23. 28.Rare Entity in Chronic Myelocytic Leukemia: Coexistence of BCR ABL1 Translocation and JAK2 V617F Mutation. Case Report Sağlam B, Albayrak M, Yıldız A, Akyol P, Pala C,Maral S, Öztürk HBA, Tığlıoğlu M, Şahin O.SN Comprehensive Clinical Medicine (2020) 2:478–480 doi.org/10.1007/s42399-020-00252-w

    Source : page de profil sur medipol.com.tr

  24. 32. Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.Gemici A, Ozkalemkas F, Dogu MH, Tekinalp A, Alacacioglu I, Guney T, Ince I, Geduk A, Cagliyan GA, Maral S, Serin I, Gunduz E, Karakus V, Bekoz HS, Eren R, Pinar IE, Gunes AK, Sargın FD, Sevindik OG. A Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e686-e692. doi: 10.1016/j.clml.2021.04.004. Epub 2021 Apr 20.

    Source : page de profil sur medipol.com.tr

  25. 39.The Importance of Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia. Öztürk HBA, Albayrak M, Yıldız A, Maral S, Akyol P, Aras MR, Falay M. UHOD , 2021:31; 199-204 doi: 10.4999/uhod.215209

    Source : page de profil sur medipol.com.tr

  26. ULAKBİM ve Diğer İndekslerde Yurt içi Eserleri:

    Source : page de profil sur medipol.com.tr

  27. 1.Thrombocytosis Associated with Iron Deficiency Anemia; Is It a Masked Myeloproliferative Disorder? Maral S. AMJ 2019:19(2);375 – 380 DOI: 10.17098/amj.570912

    Source : page de profil sur medipol.com.tr

  28. 3. Erişkin lenfoma hastalarının epidemiyolojik ve sağkalım verileri: tek merkez deneyimi. Yıldız A , Afacan Öztürk H , Albayrak M , Şahin O , Pala Öztürk Ç , Maral S , Sarıbacak Can E , Güneş G , Okutan H . Ortadoğu Tıp Dergisi. 2018; 240-246. doi.org/10.21601/ortadogutipdergisi.395616

    Source : page de profil sur medipol.com.tr

  29. 6. Kronik Lenfositik Lösemi Tanılı Olguların Klinik Seyir, Prognostik Özellikler ve Tedavi Cevabı Yönünden Değerlendirilmesi: Tek Merkez Deneyimi Öztürk HBA, Albayrak M, Pala C, Maral S, Yıldız A, Şahin O, Cömert P. Acta Oncol Tur.. 2019; 52(3): 383-387 | DOI: 10.5505/aot.2019.41033

    Source : page de profil sur medipol.com.tr

  30. Yurt İçi ve Yurt Dışı Poster ve Sözlü Sunumlar

    Source : page de profil sur medipol.com.tr

  31. 1. A Case Of Transfusion Related Acute Lung Injury (TRALI)

    Source : page de profil sur medipol.com.tr

  32. Maral S, Bakanay SM, Izdes S, Dilek I XII. Asian Assosiation of Transfusion medicine congress, IX. National transfusion medicine Congress (2016) REF NO:101 Oral Presentation-8

    Source : page de profil sur medipol.com.tr

  33. 2. Bleomycin-induced pulmonary fibrosıs: experience of two cases in a single centre. S. Maral, M. Albayrak, A. Yıldız, O. Şahin, Ç. Özturk, Ü. Malkan, G. Guneş, E. Sarıbacak Can. VIII. International Eurasian Hematology Congress / Leukemia Research 61S1 (2017),Oral presentation -32

    Source : page de profil sur medipol.com.tr

  34. 3.A case with multiple solitary plasmacytomas secreting monoclonal protein. Senem maral, Sule Mine Bakanay Aysun Senturk Yıkılmaz İmdat Dilek Internetional leukemia lymphome myeloma congres 2017 refno:65

    Source : page de profil sur medipol.com.tr

  35. 4.Does Ferritin and vitamin b12 levels have prognostik sigfiance in multiple myeloma patients?Sema akıncı,Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,imdat dile Dilek Internetional leukemia lymphome myeloma congres 2017 ref no:17 ps-08

    Source : page de profil sur medipol.com.tr

  36. 5.Multiple myeloma in Patients older Than 65 years:a comparative study with younger adult multiple myeloma patients. Sema akıncı,Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,Muhammet Bülent akıncı.imdat dilek Dilek Internetional leukemia lymphome myeloma congres 2017 ref no:14 ps-14

    Source : page de profil sur medipol.com.tr

  37. 6.The effect of gender on bone lesions in multiple myeloma patients. Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,imdat dile Dilek Internetional leukemia lymphome myeloma congres 2017ref no:65

    Source : page de profil sur medipol.com.tr

  38. 7. Importance of screening accessory spleen in refractory immune thrombocytopenia. O. Şahin, M. Albayrak, A. Yıldız, S. Maral, C. Pala Ozturk, H. Afacan Ozturk, U. Malkan, G. Guneş, E. Sarıbacak Can. VIII. International Eurasian Hematology Congress / Leukemia Research 61S1 (2017), PP-40

    Source : page de profil sur medipol.com.tr

  39. 8. Modıfıed r-idaram treatment in central nervous system lymphomas: A single centre experience. S. maral, M. albayrak, C. Pala, H.B. Afacan Ozturk, A. Yıldız, O. Şahin, H. Okutan. 23rd EHA congress, Stockholm, Sweden 2018; 2(s1) 821 (PB1797)

    Source : page de profil sur medipol.com.tr

  40. 9.Management of adult immune thrombocytopenia: single-center experience of 9 years. O. Şahin, A. Yıldız, M. Albayrak, C. Pala Ozturk, H. Afacan Ozturk, P. Comert, S. Maral. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S26, Oral Presentation-19

    Source : page de profil sur medipol.com.tr

  41. 10.A first-time report on the co-occurrence of sarcoidosis and ALK(-) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedontin treatment. H. Afacan Ozturk, M. Albayrak, C. Pala Ozturk, A. Yıldız, S. Maral, E. Onder. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S27, OralPresentation-22

    Source : page de profil sur medipol.com.tr

  42. 11. An unusual coexistence of high titer inhibitor development and gastrointestinal stromal tumor in a patient with severe hemophilia: Case report' Abdulkerim Yıldız, Osman Şahin, Okan Yayar, Çiğdem Pala Öztürk, Hacer Berna Afacan Öztürk, Senem Maral, Harika Okutan, Murat Albayrak. 11th Annual Congress of the European Association for Haemophilia and Allied Disorders, Madrid, Spain, 2018. P-169

    Source : page de profil sur medipol.com.tr

  43. 14. A rare presentation of recurrence in acute lymphoblastic leukemia: isolated optic nerve involvement. P. Comert, M. Albayrak, A. Yıldız, C. Pala Ozturk, S. Maral, H. Afacan Ozturk, O. Şahin, B. Sağlam. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S36, PP-07

    Source : page de profil sur medipol.com.tr

  44. 15. Intermittent bevacizumab therapy experience in hereditary hemorrhagic telangiectasia. O. Sahin, M. Albayrak, A. Yıldız, P. Comert, C. Ozturk, S. Maral, H. Afacan Ozturk. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S39, PP-14

    Source : page de profil sur medipol.com.tr

  45. 16. An unexpected complication: transverse myelitis after autologous stem cell transplantation. P. Comert, M. Albayrak, A. Yıldız, O. Şahin, C. Pala Ozturk, S. Maral, G. Guneş, H. Afacan Ozturk, B. Sağlam. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S43, PP-26

    Source : page de profil sur medipol.com.tr

  46. 18. Lactate Dehydrogenase Level Is Associated With A Worse Outcome In Patients With Hairy Cell Leukemia. Senem Maral, Murat Albayrak, Simten Dagdas, Abdulkerim Yıldız, Rahsan Yıldırım, Merih Oz, Cigdem Pala, Berna Ozturk, Ilker Bay, Gulsum Ozet, Imdat Dilek.24th EHA congress, Amsterdam.2019; (PB2013)

    Source : page de profil sur medipol.com.tr

  47. 20. Monoklonal Gamopati ilişkili kriyoglobunemi. Maral S. 28-29 Kasım 2020 7.Akdeniz Sempozyumu (online toplantı) Sözlu sunum

    Source : page de profil sur medipol.com.tr

  48. 21. HKNH de Aşılama. Maral S. 01-03 Ekim 2020 5.Ulusal Kan ve Kemik İliği Kongresi (online toplantı) Sözlu Sunum

    Source : page de profil sur medipol.com.tr

  49. 22. Yenı̇ Tanı Multı̇ple Myelom Hastalarında Kemı̇k İlı̇ğı̇ Fı̇brozı̇sı̇nı̇n Prognoz Ve Yanıt Üzerı̇ne Etkı̇sı̇ Var Mıdır? Maral S, Karakus V, Albayrak M, Sevindik OG46. Ulusal Hematoloji Kongresi 2020 (Online toplantı) Sözel sunu-35 Referans Numarası: 116

    Source : page de profil sur medipol.com.tr

  50. 23. Yenı̇ Tanı Yaşlı Aml Hastalarında Azacı̇tı̇dı̇n Ve Decı̇tabı̇ne İdamesı̇nı̇n Tedavı̇ye Katkısı: Gerçek Yaşam Verı̇sı̇. Karakuş V, Kaya K, Maral S, Gemici AI , Dere Y, Albayrak M, Sevindik OG 46. Ulusal Hematoloji Kongresi 2020 (Online toplantı) Sözel sunu -09 Referans Numarası: 3

    Source : page de profil sur medipol.com.tr